Home/Filings/4/0000950170-24-045698
4//SEC Filing

FRATES JAMES M 4

Accession 0000950170-24-045698

CIK 0001658551other

Filed

Apr 17, 8:00 PM ET

Accepted

Apr 18, 8:23 PM ET

Size

9.5 KB

Accession

0000950170-24-045698

Insider Transaction Report

Form 4
Period: 2024-04-16
FRATES JAMES M
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-04-16+120,000120,000 total
    Exercise: $2.01Exp: 2034-04-15Common Stock (120,000 underlying)
  • Award

    Common Stock

    2024-04-16+91,180225,964 total
Holdings
  • Common Stock

    (indirect: By Trust)
    15,459
  • Common Stock

    (indirect: By Trust)
    11,072
Footnotes (4)
  • [F1]The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest as follows: 33% on September 30, 2024, 33% on March 31, 2025 and 34% on September 30, 2025, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
  • [F2]Shares held by the James M. Frates 2024 Grantor Retained Annuity Trust No. 1, for which the Reporting Person serves as trustee and is the sole annuitant. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
  • [F3]Shares held by the FRATES FAMILY 2013 IRREV TRUST, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
  • [F4]25% of the shares subject to the option shall vest and become exercisable on April 16, 2025, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Documents

1 file

Issuer

Amylyx Pharmaceuticals, Inc.

CIK 0001658551

Entity typeother

Related Parties

1
  • filerCIK 0001235598

Filing Metadata

Form type
4
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 8:23 PM ET
Size
9.5 KB